Importance of enhanced surveillance for prevention of pertussis in children

Pediatric Infectious Disease Journal

Volumn 34, Issue 7, 2015, Pages 729-733

  Domínguez, Angela ^a,b   Godoy, Pere ^b,c   Toledo, Diana ^a,b   Soldevila, Núria ^a,b   García Cenoz, Manuel ^b,d   Farrús, Gloria ^c   Crespo, Inma ^a,b   Caylà, Joan A ^b,c   Sala, Maria Rosa ^c   Camps, Neus ^c   Barrabeig, Irene ^c   Alvarez, Josep ^c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^d INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

Author keywords

case definition; enhanced surveillance; passive surveillance; pertussis

Indexed keywords

ADOLESCENT; APNEA; ARTICLE; BRAIN DISEASE; CASE FINDING; CHILD; CONVULSION; COUGHING; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; ENHANCED SURVEILLANCE; FEMALE; FEVER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PASSIVE SURVEILLANCE; PERTUSSIS; PNEUMONIA; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPAIN; VACCINATION; VOMITING; DIAGNOSTIC TEST; EPIDEMIOLOGICAL MONITORING; INFANT; NEWBORN; ORGANIZATION AND MANAGEMENT; PATHOLOGY; PREVENTIVE HEALTH SERVICE; PROCEDURES; TRANSMISSION; WHOOPING COUGH;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIAGNOSTIC SERVICES; DIAGNOSTIC TESTS, ROUTINE; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROSPECTIVE STUDIES; SPAIN; WHOOPING COUGH;

EID: 84937519584     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000708     Document Type: Article

References (42)

1. de Melker HE, Versteegh FG, Schellekens JF, et al. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect. 2006; 53: 106-113.
2. Forsyth K., Pertussis, still a formidable foe. Clin Infect Dis. 2007; 45: 1487-1491.
3. Bart MJ, Harris SR, Advani A, et al. Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio. 2014; 5: e01074.
4. Mooi FR, Van Der Maas NA, De Melker HE., Pertussis resurgence: waning immunity and pathogen adaptation-Two sides of the same coin. Epidemiol Infect. 2014; 142: 685-694.
5. van Gent M, Bart MJ, van der Heide HG, et al. Small mutations in Bordetella pertussis are associated with selective sweeps. PLoS One. 2012; 7: e46407.
6. Gonfiantini MV, Carloni E, Gesualdo F, et al. Epidemiology of pertussis in Italy: disease trends over the last century. Euro Surveill. 2014; 19: 20921.
7. Campbell P, McIntyre P, Quinn H, et al. Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia. PLoS One. 2012; 7: e35874.
8. Rendi-Wagner P, Tobias J, Moerman L, et al. The seroepidemiology of Bordetella pertussis in Israel-estimate of incidence of infection. Vaccine. 2010; 28: 3285-3290.
9. Lasserre A, Laurent E, Turbelin C, et al. Pertussis incidence among adolescents and adults surveyed in general practices in the Paris area, France, May 2008 to March 2009. Euro Surveill. 2011; 16:pii=19783.
10. Fernández-Cano MI, Armadans L, Martínez X, et al. Incidence of whooping cough in Spain (1997-2010): an underreported disease. Eur J Pediatr. 2014; 173: 721-726.
11. Moraga F, Roca J, Méndez C, et al; TOSCA Study Group. Epidemiology and surveillance of pertussis among infants in Catalonia, Spain, during 1997-2001. Pediatr Infect Dis J. 2005; 24: 510-513.
12. Torres J, Godoy P, Artigues A, et al. [Outbreak of whooping cough with a high attack rate in well-vaccinated children and adolescents]. Enferm Infecc Microbiol Clin. 2011; 29: 564-567.
13. World Health Organization. Protocol for the Assessment of National Communicable Disease Surveillance and Response Systems. Annex 1.0 Surveillance Definitions. Geneva: World Health Organization; 2001.
14. American Academy of Pediatrics. Red Book. 2012 Report of the Committee on Infectious Diseases. 29th ed. Elk Gove Village, IL: American Academy of Pediatrics; 2012.
15. Gabutti G, Rota MC., Pertussis: a review of disease epidemiology worldwide and in Italy. Int J Environ Res Public Health. 2012; 9: 4626-4638.
16. Centers for Disease Control and Prevention. Updated guidelines for evaluating public heath surveillance systems. Recommendations from the guidelines working group. MMWR. 2001; 150: 17-20.
17. Health Surveillance Coordinating Committee. Framework and Tools for Evaluating Health Surveillance Systems. Population and Public Health Branch. Ottawa, Canada: Health Canada; 2004.
18. Barret AS, Ryan A, Breslin A, et al. Pertussis outbreak in northwest Ireland, January-June 2010. Euro Surveill. 2010; 15:pii=19654.
19. Baptista PN, Magalhães VS, Rodrigues LC., Children with pertussis inform the investigation of other pertussis cases among contacts. BMC Pediatr. 2007; 7: 21.
20. Tartof SY, Lewis M, Kenyon C, et al. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics. 2013; 131: e1047-e1052.
21. Red Nacional de Vigilancia Epidemiológica. Protocolos de las Enfermedades de Declaración Obligatoria. Madrid: Consejo Interterritorial del Sistema Nacional de salud; 2013. Available at: http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-Tecnicos/fd-vigilancias-Alertas/PROTOCOLOS-RENAVE.pdf. Accessed on September 9, 2014.
22. Cherry JD., Epidemiology of pertussis. Pediatr Infect Dis J. 2006; 25: 361-362.
23. Cortese MM, Baughman AL, Brown K, et al. A "new age" in pertussis prevention new opportunities through adult vaccination. Am J Prev Med. 2007; 32: 177-185.
24. Aksakal FN, Cöplü N, Ceyhan MN, et al. High incidence of pertussis among schoolchildren with prolonged cough in Turkey. Tohoku J Exp Med. 2007; 211: 353-358.
25. Strebel P, Nordin J, Edwards K, et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J Infect Dis. 2001; 183: 1353-1359.
26. Kuehn BM., Panel backs wider pertussis vaccination to curb outbreaks, prevent deaths. JAMA. 2010; 304: 2684-2686.
27. Sala-Farré MR, Arias-Varela C, Recasens-Recasens A, et al. Pertussis epidemic despite high levels of vaccination coverage with acellular pertussis vaccine. Enferm Infecc Microbiol Clin. 2015; 33: 27-31.
28. de Greeff SC, Lugnér AK, van den Heuvel DM, et al. Economic analysis of pertussis illness in the Dutch population: implications for current and future vaccination strategies. Vaccine. 2009; 27: 1932-1937.
29. Judelsohn RG, Koslap-Petraco MB., Public health perspectives on the rising incidence of pertussis. Public Health Nurs. 2007; 24: 421-428.
30. Fernández-Cano MI, Armadans-Gil L, Alvarez-Bartolomé M, et al. [Hospitalization due to whooping cough in Spain (1997-2011)]. Enferm Infecc Microbiol Clin. 2014; 32: 638-642.
31. Wood N, McIntyre P., Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatr Respir Rev. 2008; 9: 201-211; quiz 211.
32. Wendelboe AM, Njamkepo E, Bourillon A, et al; Infant Pertussis Study Group. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J. 2007; 26: 293-299.
33. Campins M, Moreno-Pérez D, Gil-de Miguel A, et al. [Whooping cough in Spain. Current epidemiology, prevention and control strategies. Recommendations by the Pertussis Working Group]. Enferm Infecc Microbiol Clin. 2013; 31: 240-253.
34. Zepp F, Heininger U, Mertsola J, et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis. 2011; 11: 557-570.
35. Ridda I, Yin JK, King C, et al. The importance of pertussis in older adults: a growing case for reviewing vaccination strategy in the elderly. Vaccine. 2012; 30: 6745-6752.
36. Bamberger E, Lahat N, Gershtein V, et al. Diagnosing pertussis: the role of polymerase chain reaction. Isr Med Assoc J. 2005; 7: 351-354.
37. Tatti KM, Martin SW, Boney KO, et al. Qualitative assessment of pertussis diagnostics in United States laboratories. Pediatr Infect Dis J. 2013; 32: 942-945.
38. Cagney M, MacIntyre CR, McIntyre P, et al. Cough symptoms in children aged 5-14 years in Sydney, Australia: non-specific cough or unrecognized pertussis? Respirology. 2005; 10: 359-364.
39. Ciofi Degli Atti ML, Salmaso S, Bella A, et al; Pediatric Sentinel Surveillance Study Group. Pediatric sentinel surveillance of vaccine-preventable diseases in Italy. Pediatr Infect Dis J. 2002; 21: 763-768.
40. Crowcroft NS, Stein C, Duclos P, et al. How best to estimate the global burden of pertussis? Lancet Infect Dis. 2003; 3: 413-418.
41. Grant CC, Cherry JD., Keeping pace with the elusive Bordetella pertussis. J Infect. 2002; 44: 7-12.
42. Shakib JH, Wyman L, Gesteland PH, et al. Should the pertussis case definition for public health reporting be refined? J Public Health Manag Pract. 2009; 15: 479-484.